Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

185 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia.
Nagler A, Peczynski C, Dholaria B, Labopin M, Valerius T, Dreger P, Kröger N, Reinhardt HC, Finke J, Franke GN, Ciceri F, Verbeek M, Blau IW, Bornhäuser M, Spyridonidis A, Bug G, Bazarbachi A, Schmid C, Yakoub-Agha I, Savani BN, Mohty M. Nagler A, et al. Among authors: reinhardt hc. Bone Marrow Transplant. 2022 Jul;57(7):1116-1123. doi: 10.1038/s41409-022-01693-8. Epub 2022 Apr 30. Bone Marrow Transplant. 2022. PMID: 35501565
Trends in allogeneic haematopoietic cell transplantation for myelofibrosis in Europe between 1995 and 2018: a CMWP of EBMT retrospective analysis.
McLornan D, Eikema DJ, Czerw T, Kröger N, Koster L, Reinhardt HC, Angelucci E, Robin M, Bornhäuser M, Passweg J, Clark A, Vydra J, Blau IE, Niittyvuopio R, Platzbecker U, Cornelissen JJ, Chevallier P, Srour M, Stamatovic D, Martinez-Lopez J, de Wreede L, Hayden P, Hernández-Boluda JC, Yakoub-Agha I. McLornan D, et al. Among authors: reinhardt hc. Bone Marrow Transplant. 2021 Sep;56(9):2160-2172. doi: 10.1038/s41409-021-01305-x. Epub 2021 Apr 28. Bone Marrow Transplant. 2021. PMID: 33911203
Comparison of long-term outcome for AML patients alive free of disease 2 years after allogeneic hematopoietic cell transplantation with umbilical cord blood versus unrelated donor: a study from the ALWP of the EBMT.
Baron F, Ngoya M, Labopin M, Cornelissen JJ, Ganser A, Forcade E, Sengeloev H, Socié G, Blaise D, Bornhäuser M, Valerius T, Reinhardt HC, Kröger N, Ruggeri A, Nagler A, Mohty M. Baron F, et al. Among authors: reinhardt hc. Bone Marrow Transplant. 2021 Nov;56(11):2742-2748. doi: 10.1038/s41409-021-01387-7. Epub 2021 Jul 10. Bone Marrow Transplant. 2021. PMID: 34247199 Free article.
20-Year Steady Increase in Survival of Adult Patients with Relapsed Philadelphia-Positive Acute Lymphoblastic Leukemia Post Allogeneic Hematopoietic Cell Transplantation.
Bazarbachi A, Labopin M, Aljurf M, Niittyvuopio R, Balsat M, Blaise D, Yakoub-Agha I, Grassi A, Reinhardt HC, Lenhoff S, Jindra P, Passweg J, Abou Dalle I, Stadler M, Lioure B, Ceballos P, Brissot E, Giebel S, Nagler A, Schmid C, Mohty M. Bazarbachi A, et al. Among authors: reinhardt hc. Clin Cancer Res. 2022 Mar 1;28(5):1004-1012. doi: 10.1158/1078-0432.CCR-21-2675. Clin Cancer Res. 2022. PMID: 35022319
Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis.
Gagelmann N, Wolschke C, Salit RB, Schroeder T, Ditschkowski M, Panagiota V, Cassinat B, Thol F, Badbaran A, Robin M, Reinhardt HC, Ayuk F, Heuser M, Scott BL, Kröger N. Gagelmann N, et al. Among authors: reinhardt hc. Blood Adv. 2022 Feb 22;6(4):1222-1231. doi: 10.1182/bloodadvances.2021006827. Blood Adv. 2022. PMID: 35051996 Free PMC article.
Characteristics and outcome of patients with acute myeloid leukemia and trisomy 4.
Kayser S, Martínez-Cuadrón D, Hanoun M, Stölzel F, Gil C, Reinhardt HC, Aguiar E, Schäfer-Eckart K, Burgues JMB, Steffen B, Bernal T, Krause SW, Riaza R, Schliemann C, Cervera J, Kaufmann M, Torres-Miñana L, Hänel M, Acuña-Cruz E, Jost E, Algarra JL, Crysandt M, Fransecky L, Cornago-Navascues J, Kraus S, Martinez-Lopez J, Einsele H, Niemann D, Neubauer A, Seggewiß-Bernhardt R, Scholl S, Klein SA, Schmid C, Schaich M, Schmidt-Hieber M, Zukunft S, Ho AD, Platzbecker U, Baldus CD, Müller-Tidow C, Thiede C, Bornhäuser M, Serve H, Levis M, Montesinos P, Röllig C, Schlenk RF. Kayser S, et al. Among authors: reinhardt hc. Haematologica. 2023 Jan 1;108(1):34-41. doi: 10.3324/haematol.2022.281137. Haematologica. 2023. PMID: 35678031 Free PMC article.
High Molecular and Cytogenetic Risk in Myelofibrosis Does Not Benefit From Higher Intensity Conditioning Before Hematopoietic Cell Transplantation: An International Collaborative Analysis.
Gagelmann N, Salit RB, Schroeder T, Badbaran A, Rautenberg C, Panagiota V, Wolschke C, Thol F, Cassinat B, Robin M, Heuser M, Reinhardt HC, Scott BL, Kröger N. Gagelmann N, et al. Among authors: reinhardt hc. Hemasphere. 2022 Sep 30;6(10):e784. doi: 10.1097/HS9.0000000000000784. eCollection 2022 Oct. Hemasphere. 2022. PMID: 36204690 Free PMC article.
Correction to: Impact of conditioning regimen intensity on outcomes of second allogeneic hematopoietic cell transplantation for secondary acute myelogenous leukemia.
Nagler A, Peczynski C, Dholaria B, Labopin M, Valerius T, Dreger P, Kröger N, Reinhardt HC, Finke J, Franke GN, Ciceri F, Verbeek M, Blau IW, Bornhäuser M, Spyridonidis A, Bug G, Bazarbachi A, Schmid C, Yakoub-Agha I, Savani BN, Mohty M. Nagler A, et al. Among authors: reinhardt hc. Bone Marrow Transplant. 2022 Dec;57(12):1854. doi: 10.1038/s41409-022-01834-z. Bone Marrow Transplant. 2022. PMID: 36207624 No abstract available.
185 results